Siga Technologies (SIGA) Operating Income (2010 - 2025)
Siga Technologies' (SIGA) quarterly Operating Income came in at -$10.2 million in Q3 2025, down 1985.78% on a YoY basis from $542087.0 in Q3 2024, and down 122.38% quarter-over-quarter from $45.7 million in Q2 2025.
Analysis
Siga Technologies (SIGA) Operating Income (2010 - 2025) Analysis & Trends
Siga Technologies (SIGA) has reported Operating Income for 16 consecutive years, with -$10.2 million the latest figure, recorded in Q3 2025.
- For the quarter ending Q3 2025, Operating Income fell 1985.78% year-over-year to -$10.2 million; the trailing twelve-month figure through Sep 2025 stood at $90.3 million (down 13.66% YoY), and the FY2024 full-year result was $70.0 million, down 16.31% from the prior year.
- Operating Income fell to -$10.2 million in Q3 2025 per SIGA's latest filing, from $45.7 million in the prior quarter.
- Across five years, Operating Income topped out at $94.0 million in Q4 2021 and bottomed at -$10.2 million in Q3 2025.
- Historically, Operating Income has averaged $16.8 million across 5 years, with a median of $1102.0 in 2021.
- The sharpest annual moves came in 2022 and 2025: Operating Income surged 278548.91% in 2022, then slumped 1985.78% in 2025.
- Over 5 years, Operating Income stood at $94.0 million in 2021, then plunged by 101.92% to -$1.8 million in 2022, then surged by 5179.92% to $91.7 million in 2023, then tumbled by 37.73% to $57.1 million in 2024, then sank by 117.91% to -$10.2 million in 2025.
- According to Business Quant data, Operating Income over the past three periods registered -$10.2 million, $45.7 million, and -$2.3 million for Q3 2025, Q2 2025, and Q1 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 643.26 Bn | 622.50 Bn | 17.26 Bn | 7.14 Bn |
| 2 | AbbVie | 443.31 Bn | 436.74 Bn | 12.70 Bn | 6.43 Bn |
| 3 | Merck | 364.74 Bn | 357.60 Bn | 12.21 Bn | -584.00 Mn |
| 4 | Novartis Ag | 266.46 Bn | 258.77 Bn | 11.24 Bn | 4.75 Bn |
| 5 | Pfizer | 158.57 Bn | 146.88 Bn | 10.94 Bn | 4.27 Bn |
| 6 | Sanofi | 52.33 Bn | 44.95 Bn | 10.79 Bn | 1.22 Bn |
| 7 | Revolution Medicines | 43.79 Bn | 43.79 Bn | - | -505.13 Mn |
| 8 | Incyte | 25.23 Bn | 20.69 Bn | 1.57 Bn | 697.90 Mn |
| 9 | United Therapeutics | 21.67 Bn | 19.01 Bn | 683.80 Mn | 330.80 Mn |
| 10 | Siga Technologies | 220.19 Mn | 65.22 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | -10.22 Mn |
| Jun 30, 2025 | 45.68 Mn |
| Mar 31, 2025 | -2.26 Mn |
| Dec 31, 2024 | 57.09 Mn |
| Sep 30, 2024 | 542,087.00 |
| Jun 30, 2024 | 1.08 Mn |
| Mar 31, 2024 | 11.28 Mn |
| Dec 31, 2023 | 91.68 Mn |
| Sep 30, 2023 | -1.31 Mn |
| Jun 30, 2023 | -4.64 Mn |
| Mar 31, 2023 | -2.11 Mn |
| Dec 31, 2022 | -1.80 Mn |
| Sep 30, 2022 | 42.87 Mn |
| Jun 30, 2022 | 3.07 Mn |
| Mar 31, 2022 | -1.44 Mn |
| Dec 31, 2021 | 94.02 Mn |
| Sep 30, 2021 | -2.94 Mn |
| Jun 30, 2021 | 1,102.00 |
| Mar 31, 2021 | -1.99 Mn |
| Dec 31, 2020 | 26.80 Mn |